- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03311893
Determine the Point of View of Society Society to Natural Orifice Surgeon
October 11, 2017 updated by: Ersin Gündoğan, Inonu University
the Rate of Awareness and Acceptability of Natural Orifice Surgeon in Middle Eastern Society is Similar to Other Studies
200 participants' perception and acceptability of natural hole surgeon
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
100 participants health personnel 100 participants population two group's perception and acceptability of natural orifice surgeon
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years to 100 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- all female (health personnel and population)
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: health personnel
natural orifice surgery evaluation of the awareness of the use of transvaginal, transoral and trananal approach in surgical excision and the difference between the health staff and population
|
evaluation of the awareness of the use of transvaginal, transoral and transcranial approach in surgical excision and the difference between the health staff and the pathology
|
Placebo Comparator: population
natural orifice surgery evaluation of the awareness of the use of transvaginal, transoral and trananal approach in surgical excision and the difference between the health staff and population
|
evaluation of the awareness of the use of transvaginal, transoral and transcranial approach in surgical excision and the difference between the health staff and the pathology
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
natural orifice surgery
Time Frame: 12 months
|
a survey study that measures the awareness of natural orifice surgery
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ersin Gündoğan, MD, Inonu Unıversity- general surgery
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 10, 2016
Primary Completion (Actual)
July 10, 2017
Study Completion (Actual)
August 10, 2017
Study Registration Dates
First Submitted
September 13, 2017
First Submitted That Met QC Criteria
October 11, 2017
First Posted (Actual)
October 17, 2017
Study Record Updates
Last Update Posted (Actual)
October 17, 2017
Last Update Submitted That Met QC Criteria
October 11, 2017
Last Verified
October 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 2016/199
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health, Subjective
-
Chulalongkorn UniversityNot yet recruiting
-
Prince Sattam Bin Abdulaziz UniversityCompletedHealth, SubjectiveSaudi Arabia
-
Çankırı Karatekin UniversityCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineCompleted
-
Hebrew SeniorLifeCompletedHealth, Subjective
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
Bahçeşehir UniversityNot yet recruiting
-
BMI KoreaCompletedHealth, SubjectiveKorea, Republic of
-
Alteogen, Inc.CompletedHealth, SubjectiveKorea, Republic of
-
Tel Aviv UniversityCompletedHealth, SubjectiveIsrael
Clinical Trials on natural orifice surgery
-
University Hospitals Cleveland Medical CenterCompletedProstatic Diseases | Gastric Foreign Body, Nos | Disorder of Abdomen (Disorder) | Foreign Body in Esophagus | Disease of Small IntestineUnited States
-
University Hospitals Cleveland Medical CenterTerminatedMalnutritionUnited States
-
Jaime SanchezUnknown
-
Taiyuan LiUnknownColorectal Neoplasms | Complication of Surgical Procedure | Robotic Surgical Procedures | Neoplasms Malignant | Natural Orifice Specimen Extraction SurgeryChina
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsCompleted
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedEndometrial Cancer | Extreme ObesityTurkey
-
Northwestern UniversityNatural Orifice Surgery Consortium for Assessment and ResearchCompletedEndoscopy | Appendectomy, LaparoscopicUnited States
-
Northwestern UniversityEthicon Endo-SurgeryCompletedEndoscopy | Cholecystectomy, LaparoscopicUnited States
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingSurgery | Machine Learning | Natural Orifice Specimen Extraction Surgery | Rectosigmoid CancerChina